Parkinson disease: ADAGIO trial hints that rasagiline slows disease progression.
Sampaio
Cristina
C
Ferreira
Joaquim J
JJ
D002986:Clinical Trials as Topic; D018450:Disease Progression; D016503:Drug Delivery Systems; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology*; D013997:Time Factors
D007189:Indans; D018696:Neuroprotective Agents; C031967:rasagiline